News and Trends 23 Aug 2017
Boehringer Ingelheim Enters the Clinic with Two New Diabetes Drugs
Boehringer Ingelheim starts two new Phase I trials with drugs intended to treat type 2 diabetes and obesity discovered through…
Zealand pharma
- Latest Posts
News and Trends 9 Aug 2017
Danish Diabetes Biotech Rakes in $75M on NASDAQ in American IPO
After announcing its intentions last month, Zealand Pharma has gone public in the US to fund its diabetes clinical trials.…
News and Trends 10 Jul 2017
Danish Diabetes Biotech Shoots for a €75M IPO in the US Nasdaq
Zealand Pharma, known for its partnership with Sanofi to boost the insulin blockbuster Lantus, is aiming high in an IPO…
News and Trends 18 Jan 2017
New Combo Therapy for Type 2 Diabetes to Sweep Europe
Zealand Pharma and its partner Sanofi have made it to the European market with a new combination therapy to treat…
ADVERTISEMENT
News and Trends 14 Jun 2016
Could this be the ‘Beginning of the end’ for Diabetes? Let’s Review.
Given the rates of diabetes reaching 'epidemic proportions', we figured it was time to have a better overview of biotech's…
Best in Biotech 3 May 2016
Here are 12 Biotechs you need to know in Copenhagen – Skål!
With its canals, the Little Mermaid and the oldest amusement park in the world, Copenhagen is at the heart of…
News and Trends 11 Dec 2015
Biotech of the Week: Zealand Pharma, Biotech Success Story made in Denmark
This week we say farewell to Zurich and head North, through Germany where we arrive at our next destination, the…
News and Trends 24 Nov 2015
Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC
The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment…
News and Trends 16 Sep 2015
Giving new life to Sanofi’s annual €6.2Bn diabetes blockbuster Lantus
Sanofi has announced positive results of its combination drug LixiLan phase III trials for Type 2 diabetes. Constituted from both…